CD10 - A review

被引:78
|
作者
Arber, DA
Weiss, LM
机构
[1] Division of Pathology, City of Hope National Medical Center, Duarte, CA
[2] Division of Pathology, City of Hope National Medical Center, Duarte, CA 91010
关键词
CD10; CALLA; neutral endopeptidase 24.11; acute lymphoblastic leukemia; lymphoblastic lymphoma; follicular lymphoma; Burkitt's lymphoma;
D O I
10.1097/00022744-199709000-00001
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
The antigen defined by the cluster designation group 10 (CD 10) has also been called common acute lymphoblastic leukemia antigen (CALLA) and neutral endopeptidase (NEP). This antigen is expressed by a variety of normal cell types, including lymphoid precursor cells, germinal center B lymphocytes, and some epithelial cells. On the cell surface, CD10 is an enzyme that functions to reduce the cellular response to peptide hormones. On neoplastic cells, the antigen is detected in a high percentage of cases of acute lymphoblastic leukemia (ALL), follicular lymphoma, Burkitt's lymphoma, and some nonhematopoietic tumors. CD10 is not a lineage-specific antigen, but its detection may be of value in combination with other antibodies. The detection of this antigen is most valuable in the diagnosis and classification of lymphoblastic malignancies, follicular lymphomas, and Burkitt's lymphoma.
引用
收藏
页码:125 / 140
页数:16
相关论文
共 50 条
  • [31] CD10 is frequently expressed in classical seminomas
    Del Sordo, Rachele
    Ascani, Stefano
    Bellezza, Guido
    Ferri, Ivana
    Sbaraglia, Marta
    Sidoni, Angelo
    HISTOLOGY AND HISTOPATHOLOGY, 2014, 29 (01) : 101 - 106
  • [32] CD10 immunohistochemical staining in urothelial neoplasms
    Murali, R
    Delprado, W
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2005, 124 (03) : 371 - 379
  • [33] Expression of CD10 in basal cell carcinoma
    Yada, K
    Kashima, K
    Daa, T
    Kitano, S
    Fujiwara, S
    Yokoyama, S
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2004, 26 (06) : 463 - 471
  • [34] CD10 and CD26 activity and expression in renal tumours
    Lopez, J. I.
    Blanco, L.
    Perez, I.
    Sanz, B.
    Gil, J.
    Varona, A.
    Irazusta, J.
    Andres, L.
    Gaafar, A.
    Larrinaga, G.
    VIRCHOWS ARCHIV, 2011, 459 : S285 - S286
  • [35] CD19 and CD10 coexpression in reactive lymph nodes
    Hussong, J
    Variakojis, D
    Goolsby, C
    MODERN PATHOLOGY, 1998, 11 (01) : 131A - 131A
  • [36] The diagnostic utility of CD10 in evaluating endometrial lesions
    Afify, AM
    Tan, LC
    Werness, BA
    LABORATORY INVESTIGATION, 2002, 82 (01) : 189A - 190A
  • [37] Promoter DNA methylation of CD10 in lymphoid malignancies
    K H Taylor
    J Liu
    J Guo
    J W Davis
    H Shi
    C W Caldwell
    Leukemia, 2006, 20 : 1910 - 1912
  • [38] CD10 expression in malignant Mullerian mixed tumor
    Mikami, Y
    Hata, S
    Sadahira, Y
    Manabe, T
    MODERN PATHOLOGY, 2002, 15 (01) : 203A - 203A
  • [39] High expression of CD10 in anaplastic thyroid carcinomas
    Nakazawa, Tadao
    Kondo, Tetsuo
    Vuong, Huy Gia
    Odate, Toru
    Kawai, Masataka
    Tahara, Ippei
    Kasai, Kazunari
    Inoue, Tomohiro
    Oishi, Naoki
    Mochizuki, Kunio
    Ito, Koichi
    Katoh, Ryohei
    HISTOPATHOLOGY, 2018, 73 (03) : 492 - 499
  • [40] CD10 immunoexpression in cutaneous spindle cell neoplasms
    Gardner, D. L.
    Petitt, M.
    Palmer, C. H.
    Faulkner-Jones, B. E.
    LABORATORY INVESTIGATION, 2007, 87 : 93A - 93A